This early-phase trial is testing whether a new radioactive tracer called 18F-Clofarabine (CFA) can be used in PET scans to measure an enzyme activity in cancer cells that may predict how well certain drugs like gemcitabine work. Four adults with metastatic cancer will receive th…
Phase: EARLY_PHASE1 • Sponsor: Roberto Vargas • Aim: Diagnosis
Last updated Jun 27, 2026 11:02 UTC